Gene · 7321
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanism of orphan subunit recognition during assembly quality control. | Cell | 2023 | 37480851 | PubTator, text mining | PubMed |
| Editorial: Methods in cancer genetics. | Front Oncol | 2023 | 37469406 | PubTator, text mining | PubMed |
| Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5. | EMBO J | 2023 | 37409633 | PubTator, text mining | PubMed |
| UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. | Front Genet | 2023 | 37377594 | PubTator, text mining | PubMed |
| Reviewing Atrial Fibrillation Pathophysiology from a Network Medicine Perspective: The Relevance of Structural Remodeling, Inflammation, and the Immune System. | Life (Basel) | 2023 | 37374146 | PubTator, text mining | PubMed |
| The CUL4B-based E3 ubiquitin ligase regulates mitosis and brain development by recruiting phospho-specific DCAFs. | EMBO J | 2023 | 37365982 | PubTator, text mining | PubMed |
| Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. | Nat Commun | 2023 | 37353483 | PubTator, text mining | PubMed |
Inflammasome activation and metabolic remodelling in p16-positive aging cells aggravates high-fat diet-induced lung fibrosis by inhibiting NEDD4L-mediated K48-polyubiquitin-dependent degradation of SGK1. | Clin Transl Med | 2023 | 37345264 | PubTator, text mining | PubMed |
| Autistic spectrum disorder (ASD) - Gene, molecular and pathway signatures linking systemic inflammation, mitochondrial dysfunction, transsynaptic signalling, and neurodevelopment. | Brain Behav Immun Health | 2023 | 37334258 | PubTator, text mining | PubMed |
| The E3 Ubiquitin Ligase, CHIP/STUB1, Inhibits Aggregation of Phosphorylated Proteoforms of Microtubule-associated Protein Tau (MAPT). | J Mol Biol | 2023 | 37330289 | PubTator, text mining | PubMed |
| Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis. | Int J Med Sci | 2023 | 37324184 | PubTator, text mining | PubMed |
| Speaking the host language: how Salmonella effector proteins manipulate the host. | Microbiology (Reading) | 2023 | 37279149 | PubTator, text mining | PubMed |
| Hybrid-seq deciphers the complex transcriptional profile of the human BRCA1 DNA repair associated gene. | RNA Biol | 2023 | 37272060 | PubTator, text mining | PubMed |
| SIRT1 ubiquitination is regulated by opposing activities of APC/C-Cdh1 and AROS during stress-induced premature senescence. | Exp Mol Med | 2023 | 37258580 | PubTator, text mining | PubMed |
| Screening and Verification of Key Ubiquitination Genes Related to Immune Infiltration in Stage III/IV Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37250505 | PubTator, text mining | PubMed |
| The E2 ubiquitin-conjugating enzymes UBE2D1 and UBE2D2 regulate VEGFR2 dynamics and endothelial function. | J Cell Sci | 2023 | 37226882 | PubTator, text mining | PubMed |
| A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells. | Nat Commun | 2023 | 37225719 | PubTator, text mining | PubMed |
| S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. | Breast Cancer Res | 2023 | 37217945 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy. | Front Immunol | 2023 | 37215134 | PubTator, text mining | PubMed |
| Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development. | Blood Adv | 2023 | 37205848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7321/papers?page=5